BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 10746047)

  • 21. Ambulatory care for ambulant patients with deep vein thrombosis.
    Blattler W
    J Mal Vasc; 1991; 16(2):137-41. PubMed ID: 1861106
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deep venous thrombosis in children and adolescents.
    Levy ML; Granville RC; Hart D; Meltzer H
    J Neurosurg; 2004 Aug; 101(1 Suppl):32-7. PubMed ID: 16206969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [How to provide practical treatment for ambulatory patients with deep venous thrombosis].
    Achkar A; Samama MM
    J Mal Vasc; 1999 Feb; 24(1):58-65. PubMed ID: 10192039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost implications of low molecular weight heparins as prophylaxis following total hip and knee replacement.
    Bell GK; Goldhaber SZ
    Vasc Med; 2001; 6(1):23-9. PubMed ID: 11358156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Short-term and long-term evolution of deep vein thrombosis treated by a health care unit].
    Martín-Carbonero L; Salgado X; Pedrajas JM; Armengol JG; Jiménez Rodríguez-Madridejos R; Fernández-Cruz A
    Rev Clin Esp; 2002 Aug; 202(8):430-4. PubMed ID: 12199992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis.
    Naz R; Naz S; Mehboob M; Khalid GH
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):601-4. PubMed ID: 19810295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prospective 12-year follow-up study of clinical and hemodynamic sequelae of deep venous thromboses in patients with low risk (Zurich Study)].
    Franzeck UK; Schalch I; Jäger KA; Grimm ES; Bollinger A
    Wien Med Wochenschr; 1999; 149(2-4):78-84. PubMed ID: 10378331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of venous thrombosis with low molecular weight heparin. Progress and outlook].
    Fiessinger JN
    Bull Acad Natl Med; 1997 May; 181(5):875-83; discussion 883-5. PubMed ID: 9312362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Treatment of established venous thrombosis with low molecular weight heparins. A critical review].
    Bounameaux H
    J Mal Vasc; 1991; 16(2):129-32. PubMed ID: 1650390
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Home-treatment of deep vein thrombosis in patients with cancer.
    Ageno W; Grimwood R; Limbiati S; Dentali F; Steidl L; Wells PS
    Haematologica; 2005 Feb; 90(2):220-4. PubMed ID: 15710575
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Secondary prevention after deep venous thrombosis. Low molecular weight heparin versus coumarin].
    Hamann H
    Zentralbl Chir; 1999; 124(1):24-6. PubMed ID: 10091293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of ambulatory and inpatient treatment of acute deep venous thrombosis of the leg: subjective and economic aspects].
    Frank D; Blättler W
    Schweiz Med Wochenschr; 1998 Sep; 128(36):1328-33. PubMed ID: 9784675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey.
    Voke J; Keidan J; Pavord S; Spencer NH; Hunt BJ;
    Br J Haematol; 2007 Nov; 139(4):545-58. PubMed ID: 17916101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An open-label, comparative study of the efficacy and safety of once-daily dose of enoxaparin versus unfractionated heparin in the treatment of proximal lower limb deep-vein thrombosis.
    Ramacciotti E; Araújo GR; Lastoria S; Maffei FH; Karaoglan de Moura L; Michaelis W; Sandri JL; Dietrich-Neto F;
    Thromb Res; 2004; 114(3):149-53. PubMed ID: 15342210
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outpatient treatment of deep vein thrombosis with LMWH.
    Koopman MM
    Wien Med Wochenschr; 1999; 149(2-4):46-9; discussion 49. PubMed ID: 10378322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Physical treatment of deep venous thrombosis: bed rest or mobilization?].
    Manganaro A; Buda D; Calabro D; Tati' L; Consolo F
    Minerva Cardioangiol; 2000 Dec; 48(12 Suppl 1):53-6. PubMed ID: 11253341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
    Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
    Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy.
    Delis KT; Hunt N; Strachan RK; Nicolaides AN
    Thromb Haemost; 2001 Sep; 86(3):817-21. PubMed ID: 11583313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low molecular weight heparin administered once versus twice daily in patients with venous thromboembolism: a meta-analysis.
    Couturaud F; Julian JA; Kearon C
    Thromb Haemost; 2001 Oct; 86(4):980-4. PubMed ID: 11686355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.